Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
RESEARCH TOOLSreports
Prime Medicine, Inc. (PRME) Ownership - Who Owns Prime Medicine, Inc.?
73 Followers
Prime Medicine, Inc. (PRME) Ownership Overview
80.49% Insiders
6.11% Mutual Funds
11.39% Other Institutional Investors
2.01% Public Companies and
Individual Investors
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail and individual investors. Approximately 17.50% of the company’s stock is owned by Institutional Investors, 80.49% is owned by Insiders and 2.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 20, 2024 | Arch Venture Partners Xii, Llc >10% Owner | Bought | $20000000 |
| Feb 20, 2024 | Arch Venture Partners X, Llc >10% Owner | Bought | $20000000 |
| Feb 20, 2024 | Robert Nelsen Director, >10% Owner | Bought | $20000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $312182 | |
| Dec 31, 2023 | Bought | $352955 | |
| Dec 31, 2023 | Bought | $1063731 | |
| Dec 31, 2023 | Bought | $27805072 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,633,159 | Institution | 4.70% | 29,686,748 | |
| 5,473,170 | Institution | 4.56% | 28,843,606 | |
| 3,770,491 | Institution | 3.14% | 19,870,488 | |
| 3,138,270 | Institution | 2.62% | 16,538,683 | |
| 1,787,316 | Institution | 1.49% | 9,419,155 | |
| 1,445,746 | Institution | 1.21% | 7,619,081 | |
| 1,028,466 | Institution | 0.86% | 5,420,016 | |
| 885,314 | Institution | 0.74% | 4,665,605 | |
| 446,733 | Institution | 0.37% | 2,354,283 | |
| 427,128 | Institution | 0.36% | 2,250,965 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,770,491 | Institution | 3.14% | 19,870,488 | |
| 1,445,746 | Institution | 1.21% | 7,619,081 | |
| 427,128 | Institution | 0.36% | 2,250,965 | |
| 395,087 | Institution | 0.33% | 2,082,108 | |
| 360,982 | Institution | 0.30% | 1,902,375 | |
| 301,006 | Institution | 0.25% | 1,586,302 | |
| 163,988 | Institution | 0.14% | 864,217 | |
| 110,228 | Institution | 0.09% | 580,902 | |
| 85,602 | Institution | 0.07% | 451,123 | |
| 53,800 | Institution | 0.04% | 283,526 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,949,120 | Institution | 2.46% | 15,541,862 | |
| 2,011,807 | Institution | 1.68% | 14,082,649 | |
| 2,524,050 | Institution | 2.10% | 13,301,744 | |
| 1,722,718 | Institution | 1.44% | 12,059,026 | |
| 977,499 | Institution | 0.81% | 6,842,493 | |
| 966,836 | Institution | 0.81% | 5,095,226 | |
| 593,826 | Institution | 0.50% | 4,156,782 | |
| 347,579 | Institution | 0.29% | 1,831,741 | |
| 279,884 | Institution | 0.23% | 1,474,989 | |
| 146,296 | Institution | 0.12% | 1,024,072 |
FAQ
Who Owns Prime Medicine, Inc. (PRME)?
According to the latest TipRanks data, approximately 11.39% of the company's stock is held by institutional investors, 80.49% is held by insiders, and 2.01% is held by retail investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.39% of Prime Medicine, Inc. (PRME) stock is held by institutional investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.01% of Prime Medicine, Inc. (PRME) stock is held by retail investors.
Who owns the most shares of Prime Medicine, Inc. (PRME)?
Vanguard owns the most shares of Prime Medicine, Inc. (PRME).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.